作者
Chang-Sheng Ma,Yu-Xi Liu,Xiao-Bing Hu,Shi-Chun Ren,Yan Lu,Xiao-Ru Sun,Yu-Jie Song,Si Li,Zhendong Xu
摘要
Background Microplastics cross the blood–brain barrier and accumulate in human brain tissue, yet the molecular mechanisms linking polyethylene terephthalate (PET) to Alzheimer’s disease (AD) remain poorly defined. Methods We integrated network pharmacology, single-cell transcriptomics, ROC analysis, molecular docking, and Mendelian randomization (MR) to identify candidate targets, and tested the principal predictions in cultured astrocytes exposed to characterized PET nanospheres. Results Thirty-nine consensus targets intersected PET toxicity, neuroinflammation, and AD, and six topological measures nominated AKT1, mTOR, SRC, PTGS2, and CASP3 as core hub genes. AKT1, mTOR, SRC, and PTGS2 were enriched in astrocyte subcluster 3 and CASP3 in subcluster 5. A five-gene ridge model showed region-dependent discrimination, and MR supported SRC, AKT1, and mTOR as causal candidates. PET nanospheres (82.5 nm, −45.4 mV) entered astrocytes, reduced viability to 42.2% at 100 μg/mL, increased ROS and the release of IL-1β, IL-6, and TNF-α, activated SRC/AKT1/mTOR signaling, and shifted astrocytes toward an A1-like phenotype. PP2 partially rescued these responses, and DARTS confirmed direct PET engagement of SRC and AKT1. Conclusions PET nanoplastics engage the SRC/AKT1/mTOR axis in astrocytes and may contribute to AD-associated neuroinflammation; the candidate pathway warrants validation in model organisms and human cohorts.